Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with ...

Breast cancers at all stages are defined by the structure of their genomes, researchers find. Targeting these processes early is likely to offer unexpected therapeutic avenues.

There are several associated risk factors, including hereditary and acquired genetic mutations (alterations in the DNA), and the influence of hormones. Learn More Causes and Risk Factors of Ovarian ...

Surgery may include lobectomy, thyroidectomy and/or lymph node removal. Thyroid hormone replacement is needed after the removal of the thyroid gland. Anaplastic thyroid cancer, a rare type, is highly ...

Researchers found no link between hormone therapy and gliomas, the most common brain tumors in adults, according to results of a new study published recently in the journal Menopause. “Compared with ...

We present a case of a woman who developed OHSS due to an FSH-secreting pituitary adenoma ... thereby avoiding multiple therapeutic procedures for ovarian cysts and ultimately also restoring ...

This approval marks a significant advancement in the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer. The efficacy of datopotamab ...

Siteman Cancer Center at Washington University. But too much estrogen over a lifetime can lead to the formation and growth of cancerous cells. Over time, there have been several population-level ...

People who carry mutated versions of certain genes may be at a higher risk of developing ovarian cancer. The most common mutations associated with ovarian cancer include those in the breast cancer ...